Abstract
The present study was aimed to evaluate the rehabilitation conditions of Parkinson's disease patients using combined therapy of Bushenzhichan formula and needle embedding and analyze the Magnetic resonance imaging test results. In this investigation, 180 Parkinson's disease patients treated at the Beijing Rehabilitation Hospital were enrolled as study subjects. They were randomly divided into the control group and the research group, each containing 90 patients. The research group was treated with Madopar as well as combined therapy of Bushenzhichan formula and needle embedding, while the control group was given only Madopar. The rehabilitation conditions of the 2 groups were compared. The total therapeutic efficacy of the research group was higher than that of the control group (p<0.05). By comparing the unified parkinson's disease rating scale I, unified parkinson's disease rating scale II and unified parkinson's disease rating scale III scores after treatment, the research group showed significant improvement over the control group (p<0.05). Moreover, Magnetic resonance imaging results showed low signal intensity in the red nucleus and substantia nigra. There was no significant difference in the volume of red nucleus and substantia nigra between the two groups. The combined therapy of Bushenzhichan formula and needle embedding could significantly improve the therapeutic efficacy and promote recovery in Parkinson disease patients.
Author supplied keywords
Cite
CITATION STYLE
Guo, L., Zhang, C., Wang, J., Teng, J., Feng, G., & Lu, M. (2020). Evaluation of rehabilitation and mri results of the combined therapy of bushenzhichan formula and needle embedding for parkinson’s disease. Indian Journal of Pharmaceutical Sciences, 82, 55–58. https://doi.org/10.36468/pharmaceutical-sciences.spl.36
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.